from Eli Lilly before 27 September. Novartis and Amgen already have a CGRP drug on the market – Aimovig (erenumab) was approved in the US in May. Teva has priced its monthly injection at $575 ...

Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...

Teva and Alvotech have been working together ... of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket Eli Lilly Cuts Price of Weight-Loss Drug Zepbound for Self-Pay Patients AbbVie ...

Teladoc and LifeMD are partnering with drugmaker Eli Lilly to offer the weight loss drug Zepbound directly to self-paying patients. The two telehealth companies said Thursday they’re working ...

Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Lilly is launching two new doses and cutting prices for self-paying customers Eli Lilly & Co. said Tuesday it's cutting the price of single-dose vials of its Zepbound treatment for diabetes and ...

Additionally, Teladoc Health (TDOC) signed an agreement with Eli Lilly’s (LLY) LillyDirect pharmacy partner, Gifthealth, to help streamline access to the weight-loss drug Zepbound. Another stock ...